FDA Adverse Event Malfunction Summary report: N

COBAS INTEGRA 400 PLUS

MDR report key: 1934697 · Received December 21, 2010

Report

Report Number
1823260-2010-07596
Event Type
Malfunction
Date Received
December 21, 2010
Date of Event
December 9, 2010
Report Date
December 21, 2010
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K951595
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Description of Event or Problem · 1

THE CUSTOMER ALLEGED QUESTIONABLE ALBUMIN GEN. 2, CALCIUM, AND TINA- QUANT HEMOGLOBIN A1C GEN.2 (A1C) RESULTS ON EIGHT PATIENT SAMPLES TESTED ON THE COBAS INTEGRA 400 PLUS. THE A1C RESULTS WERE FOUND TO BE DISCREPANT. THE INITIAL A1C OBTAINED ON THE SAMPLE WAS 9.26%, WHICH WAS REPORTED OUTSIDE THE LABORATORY. THE REPEAT A1C WAS 6.6%; THIS RESULT WAS SENT OUT AS A CORRECTED REPORT. THE CUSTOMER STATED THE DOCTOR'S OFFICE QUESTIONED THE INITIAL RESULT IMMEDIATELY AND THE PATIENT WAS NOT AFFECTED BY THE DISCREPANT RESULT. THE LOT NUMBER OF A1C REAGENT IN USE WAS NOT PROVIDED. THE FIELD SERVICE REPRESENTATIVE DETERMINED THAT A PROBE WAS NOT PROPERLY SCREWED INTO THE HOLDER. HE REPLACED THE PROBE. THE CUSTOMER PERFORMED CALIBRATION AND PERFORMANCE TESTS, WHICH PASSED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COBAS INTEGRA 400 PLUS CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1 077 YR